Drug Interactions between THC and Carbamazepine

Introduction to THC and Carbamazepine Interaction

THC can potentially interact with carbamazepine through inhibition of CYP450 enzymes, particularly CYP2C9, which may increase carbamazepine levels and risk of toxicity, requiring careful monitoring if concurrent use cannot be avoided 1
The American College of Clinical Oncology suggests that THC inhibits several cytochrome P450 enzymes, including CYP3A4, CYP2C9, CYP1A2, CYP2B6, CYP2C8, and CYP2C19, which are involved in carbamazepine metabolism 1

The clinical significance of this interaction appears to be moderate based on available evidence, with cannabis and cannabinoids generally having a "low probability of clinically relevant drug interactions" with most medications, but specific interactions with antiepileptic drugs like carbamazepine warrant caution 1
Higher THC doses (>20 mg/day of THC oil) may increase the risk of interaction, especially with oral THC products due to first-pass metabolism, and chronic rather than occasional cannabis use 2

If a patient is using both carbamazepine and THC, it is recommended to monitor carbamazepine levels more frequently, especially when starting THC use, changing THC dosage, or discontinuing THC, and to watch for signs of carbamazepine toxicity such as dizziness, drowsiness, and nausea 1
Consistent THC dosing is crucial to avoid unpredictable fluctuations in carbamazepine levels, and starting THC at low doses and increasing slowly is recommended if concurrent use is necessary 2
Educating patients about potential interaction risks, signs of carbamazepine toxicity, and the importance of disclosing cannabis use to healthcare providers is essential 2

Considering alternative anticonvulsants with fewer drug interactions may be appropriate for the patient's condition, and the route of administration matters, with inhaled THC potentially having less interaction potential than oral forms due to bypassing first-pass metabolism 1
Separating doses of THC and carbamazepine may help minimize interaction, and individual variability in CYP enzyme activity may affect the magnitude of this interaction 1